Cargando…

Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan

Pyrethroid insecticides are the only pesticides approved for the treatment of head lice (pediculosis capitis) infestations in Japan. However, in Okinawa Prefecture, 96% of head lice are resistant to pyrethroids. Here, we conducted a clinical trial to assess the safety and efficacy of a dimethicone p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Sayaka, Yasumura, Ryo, Okamoto, Yuka, Okubo, Yuko, Miyagi, Takuya, Kawada, Hitoshi, Takahashi, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453846/
https://www.ncbi.nlm.nih.gov/pubmed/34048065
http://dx.doi.org/10.1111/1346-8138.15966
_version_ 1784570360181555200
author Yamaguchi, Sayaka
Yasumura, Ryo
Okamoto, Yuka
Okubo, Yuko
Miyagi, Takuya
Kawada, Hitoshi
Takahashi, Kenzo
author_facet Yamaguchi, Sayaka
Yasumura, Ryo
Okamoto, Yuka
Okubo, Yuko
Miyagi, Takuya
Kawada, Hitoshi
Takahashi, Kenzo
author_sort Yamaguchi, Sayaka
collection PubMed
description Pyrethroid insecticides are the only pesticides approved for the treatment of head lice (pediculosis capitis) infestations in Japan. However, in Okinawa Prefecture, 96% of head lice are resistant to pyrethroids. Here, we conducted a clinical trial to assess the safety and efficacy of a dimethicone preparation against head lice infestations in Okinawa Prefecture. Dimethicone‐containing lotion was applied over the entire scalp three times over a 7‐day period. Lice bodies (nymphs/adults) and eggs (nits) were counted before (day 0) and after treatment (day 8); a subset of eggs was collected to estimate viability based on hatch rate. Efficacy was evaluated based on improvement (reduction) in head lice counts post‐treatment with respect to baseline. Safety was evaluated based on subjects’ scalp condition and adverse event incidence. Utility was a composite end‐point combining efficacy and safety. In total, 35 subjects were enrolled. Efficacy and safety were evaluated in 23 and 35 subjects, respectively. No side‐effects of note were reported during the treatment period. The dimethicone lotion resulted in a utility rating of “marginally useful” or higher in over 80% of the study population, signifying the formulation to be both safe and effective. The dimethicone lotion was also a potent ovicide; 99.4% of eggs collected after treatment failed to hatch when incubated. Eradication of head lice remained successful for at least 4 weeks after the final topical dimethicone application in 25 of the 28 subjects reached by telephone survey. Lice bodies and eggs were genotyped to analyze the prevalence of three knockdown resistance (kdr)‐type mutations within the voltage‐sensitive sodium channel known to confer pyrethroid resistance. One or more kdr mutations were confirmed in 30 of the 32 subjects from whom specimens were collected (93.8%). Dimethicone was confirmed to be both safe and effective in treating pyrethroid‐resistant head lice.
format Online
Article
Text
id pubmed-8453846
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84538462021-09-27 Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan Yamaguchi, Sayaka Yasumura, Ryo Okamoto, Yuka Okubo, Yuko Miyagi, Takuya Kawada, Hitoshi Takahashi, Kenzo J Dermatol Original Articles Pyrethroid insecticides are the only pesticides approved for the treatment of head lice (pediculosis capitis) infestations in Japan. However, in Okinawa Prefecture, 96% of head lice are resistant to pyrethroids. Here, we conducted a clinical trial to assess the safety and efficacy of a dimethicone preparation against head lice infestations in Okinawa Prefecture. Dimethicone‐containing lotion was applied over the entire scalp three times over a 7‐day period. Lice bodies (nymphs/adults) and eggs (nits) were counted before (day 0) and after treatment (day 8); a subset of eggs was collected to estimate viability based on hatch rate. Efficacy was evaluated based on improvement (reduction) in head lice counts post‐treatment with respect to baseline. Safety was evaluated based on subjects’ scalp condition and adverse event incidence. Utility was a composite end‐point combining efficacy and safety. In total, 35 subjects were enrolled. Efficacy and safety were evaluated in 23 and 35 subjects, respectively. No side‐effects of note were reported during the treatment period. The dimethicone lotion resulted in a utility rating of “marginally useful” or higher in over 80% of the study population, signifying the formulation to be both safe and effective. The dimethicone lotion was also a potent ovicide; 99.4% of eggs collected after treatment failed to hatch when incubated. Eradication of head lice remained successful for at least 4 weeks after the final topical dimethicone application in 25 of the 28 subjects reached by telephone survey. Lice bodies and eggs were genotyped to analyze the prevalence of three knockdown resistance (kdr)‐type mutations within the voltage‐sensitive sodium channel known to confer pyrethroid resistance. One or more kdr mutations were confirmed in 30 of the 32 subjects from whom specimens were collected (93.8%). Dimethicone was confirmed to be both safe and effective in treating pyrethroid‐resistant head lice. John Wiley and Sons Inc. 2021-05-28 2021-09 /pmc/articles/PMC8453846/ /pubmed/34048065 http://dx.doi.org/10.1111/1346-8138.15966 Text en © 2021 Japanese Dermatological Association https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Yamaguchi, Sayaka
Yasumura, Ryo
Okamoto, Yuka
Okubo, Yuko
Miyagi, Takuya
Kawada, Hitoshi
Takahashi, Kenzo
Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title_full Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title_fullStr Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title_full_unstemmed Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title_short Efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, Okinawa, Japan
title_sort efficacy and safety of a dimethicone lotion in patients with pyrethroid‐resistant head lice in an epidemic area, okinawa, japan
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453846/
https://www.ncbi.nlm.nih.gov/pubmed/34048065
http://dx.doi.org/10.1111/1346-8138.15966
work_keys_str_mv AT yamaguchisayaka efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT yasumuraryo efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT okamotoyuka efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT okuboyuko efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT miyagitakuya efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT kawadahitoshi efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan
AT takahashikenzo efficacyandsafetyofadimethiconelotioninpatientswithpyrethroidresistantheadliceinanepidemicareaokinawajapan